All the news Showing 10 of 76 articles.Get an RSS feed of these articles Show All news infohep newsEditors' picks from other sources Johns Hopkins approved to perform first HIV-positive to HIV-positive organ transplants in U.S. Johns Hopkins Medicine / 09 February 2016 U.S. FDA Approves Expanded Use of Bristol-Myers Squibb’s Daklinza (daclatasvir) for Additional Challenging-to-treat Patients with Genotype 1 or Genotype 3 Chronic Hepatitis C Bristol-Myers Squibb press release / 08 February 2016 Olysio/Sovaldi yield high SVR post-liver transplant Healio / 08 February 2016 Daclatasvir approved for use in HIV/HCV co-infection, decompensated cirrhosis and post-transplant in the EU Keith Alcorn / 03 February 2016 The hepatitis C direct-acting antiviral daclatasvir (Daklinza) has received European Union marketing approval for use in three new populations of people with genotype 1, 3 or 4 hepatitis C infection. The NS5A inhibitor ... European Commission Approves Daklinza (daclatasvir) for the Treatment of Genotype 1, 3 and 4 Chronic Hepatitis C Patients with HIV Coinfection, Advanced Cirrhosis and Post-liver Transplant Recurrence of HCV Bristol-Myers Squibb press release / 01 February 2016 Clinical impact of effective HCV DAAs: referrals for liver transplant drop after their introduction Keith Alcorn / 04 December 2015 The number of hepatitis C virus (HCV)-related referrals for liver transplant has declined significantly since the introduction of HCV direct-acting antivirals (DAAs), according to two US studies presented to the recent 2015 ... Liver transplants in HIV/HCV co-infection: study underlines importance of hepatitis C treatment Keith Alcorn / 29 June 2015 People with HIV and hepatitis C co-infection were significantly more likely to experience organ rejection than people with hepatitis C alone or HIV alone after undergoing a liver transplant, according to a ... HCV at a Crossroads:The Pre- or Post-Transplant Treatment Debate Healio HCV Next / 15 June 2015 Civacir immune globulin may help prevent HCV reinfection after liver transplant Liz Highleyman / 18 May 2015 Civacir, a hepatitis C immune globulin or antibody product, reduced the likelihood of hepatitis C virus infecting the new liver graft after transplantation in people who were receiving, but had not yet ... HIV did not affect HCC recurrence or survival after liver transplant Healio Hepatology / 04 March 2015 ← Prev1...34567...8Next → Other pages in this section Latest news All the news Hepatitis A Hepatitis B Hepatitis C Hepatitis D Hepatitis E Coronavirus NAFLD Treatment for hepatocellular carcinoma Transmission, epidemiology and prevention Health services, policy and advocacy Social issues Conference news Email bulletin archive